According to the latest report published by Data Bridge Market Research, the  Bulbospinal Muscular Atrophy Drugs Market Data Bridge Market Research analyses that the bulbospinal muscular atrophy drugs market which was USD 690.60 million in 2022, would reach up to USD 1,793.48 million by 2030, and is expected to undergo a CAGR of 12.67% during the forecast period.  The...